The biological effect of intrapleural tissue plasminogen (tPA) activator and DNase delivery in pleural infection patients.
N. Kanellakis (Oxford, United Kingdom), J. Wrightson (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), M. Fayed (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Kanellakis (Oxford, United Kingdom), J. Wrightson (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), M. Fayed (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom). The biological effect of intrapleural tissue plasminogen (tPA) activator and DNase delivery in pleural infection patients.. 5456
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: